IL-33 promotes airway remodeling and is a marker of asthma disease severity

Journal of Asthma

Volumn 51, Issue 8, 2014, Pages 863-869

  Guo, Zhi ^a,b   Wu, Jinxiang ^a   Zhao, Jiping ^a   Liu, Fen ^a   Chen, Yingjian ^b   Bi, Liquan ^b   Liu, Shuying ^b   Dong, Liang ^a  

^a SHANDONG UNIVERSITY   (China)

^b JINAN MILITARY GENERAL HOSPITAL   (China)

Author keywords

Airway remodeling; Asthma; HLF 1; IL 33; ST2

Indexed keywords

COLLAGEN TYPE 1; FIBRONECTIN; FIBRONECTIN1 PROTEIN; FLUTICASONE PROPIONATE; IMMUNOGLOBULIN E; INTERLEUKIN 33; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; IL33 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ADULT; AIRWAY REMODELING; ARTICLE; ASTHMA; BRONCHUS BIOPSY; BRONCHUS MUCOSA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; EOSINOPHIL COUNT; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LUNG FIBROBLAST; LUNG FUNCTION; MALE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SPUTUM; BLOOD; HLF-1; IL-33; PATHOPHYSIOLOGY; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX; ST2;

AIRWAY REMODELING; ASTHMA; HLF-1; IL-33; ST2;

ADULT; AIRWAY REMODELING; ASTHMA; BIOLOGICAL MARKERS; FEMALE; HUMANS; INTERLEUKINS; MALE; SEVERITY OF ILLNESS INDEX;

EID: 84903886705     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770903.2014.921196     Document Type: Article

References (32)

1. Baekkevold ES, Roussigne M, Yamanaka T, Johansen FE, Jahnsen FL, Amalric F, Brandtzaeg P, et al. Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am J Pathol 2003;163:69-79.
2. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Zurawski G, et al. IL-33,an interleukin 1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-Associated cytokines. Immunity 2005;23:479-490.
3. Lee HY, Rhee CK, Kang JY, Byun JH, Choi JY, Kim SJ, Kim YK, et al. Blockade of IL-33/ST2 ameliorates airway inflammation in a murine model of allergic asthma. Exp Lung Res 2014;40:66-76.
4. Broide DH. Immunologic and inflammatory mechanisms that drive asthma progression to remodeling. J Allergy Clin Immunol 2008; 121:560-570.
5. Kaminska M, Foley S, Maghni K, Storness-Bliss C, Coxson H, Ghezzo H, Lemiére C, et al. Airway remodeling in subjects with severe asthma with or without chronic persistent airflow obstruction. J Allergy Clin Immunol 2009;124:45-51e1-e4.
6. Pascual RM, Peters SP. Airway remodeling contributes to the progressive loss of lung function in asthma: An overview. J Allergy Clin Immunol 2005;116:477-486.
7. IRoche WR, Beasley R, Williams JH, Holgate ST. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989;1:520-524.
8. Huang J, Olivenstein R, Taha R, Hamid Q, Ludwig M. Enhanced proteoglycan deposition in the airway wall of atopic asthmatics. Am J Respir Crit Care Med 1999;160:725-729.
9. Wilson JW, Li X. The measurement of reticular basement membrane and submucosal collagen in the asthmatic airway. Clin Exp Allergy 1997;27:363-371.
10. Karjalainen EM, Lindqvist A, Laitinen LA, Kava T, Altraja A, Halme M, Laitinen A. Airway inflammation and basement membrane tenascin in newly diagnosed atopic and nonatopic asthma. Respir Med 2003;97:1045-1051.
11. Oshikawa K, Kuroiwa K, Tago K, Iwahana H, Yanagisawa K, Ohno S, Tominaga SI, Sugiyama Y. Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am J Respir Crit Care Med 2001;164:277-281.
12. Préfontaine D, Lajoie-Kadoch S, Foley S, Audusseau S, Olivenstein R, Halayko AJ, Lemiére C, et al. Increased expression of IL-33 in severe asthma: Evidence of expression by airway smooth muscle cells. Immunol 2009;183:5094-5103.
13. Pin I, Gibson PG, Kolendowicz R, Girgis-Gabardo A, Denburg JA, Hargreave FE, Dolovich J. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992;47:25-29.
14. Feltis BN, Wignarajah D, Zheng L, Ward C, Reid D, Harding R, Walters EH. Increased vascular endothelial growth factor and receptors: Relationship to angiogenesis in asthma. Am J Respir Crit Care Med 2006;173:1201-1207.
15. Tajima S, Bando M, Ohno S, Sugiyama Y, Oshikawa K, Tominaga S, Itoh K, et al. ST2 gene induced by type 2 helper T cell (Th2) and proinflammatory cytokine stimuli may modulate lung injury and fibrosis. Exp Lung Res 2007;33:81-97.
16. Préfontaine D, Nadigel J, Chouiali F, Audusseau S, Semlali A, Chakir J, Martin JG, Hamid Q. Increased IL-33 expression by epithelial cells in bronchial asthma. J Allergy Clin Immunol 2010; 125:752-754.
17. Moussion C, Ortega N, Girard JP. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: A novel alarmin. PLoS One 2008;3: E3331.
18. Hamzaoui A, Berraies A, Kaabachi W, Haifa M, Ammar J, Kamel H. Induced sputum levels of IL-33 and soluble ST2 in young asthmatic children. J Asthma 2013;50:803-809.
19. Kim HY, Chang YJ, Subramanian S, Lee HH, Albacker LA, Matangkasombut P, Savage PB, et al. Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity. J Allergy Clin Immunol 2012;129: 216-227e1-e6.
20. Barlow JL, Bellosi A, Hardman CS, Drynan LF, Wong SH, Cruickshank JP, McKenzie AN. Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity. J Allergy Clin Immunol 2012;129:191-198e1-e4.
21. Stolarski B, Kurowska-Stolarska M, Kewin P, Xu D, Liew FY. L-33 exacerbates eosinophil-mediated airway inflammation. J Immunol 2010;185:3472-3480.
22. Lai Y, Altemeier WA, Vandree J, Piliponsky AM, Johnson B, Appel CL, Frevert CW, et al. Increased density of intraepithelial mast cells in patients with exercise-induced bronchoconstriction regulated through epithelially derived thymic stromal lymphopoietin and IL-33. J Allergy Clin Immunol 2014;133:1448-55.
23. Barlow JL, Peel S, Fox J, Panova V, Hardman CS, Camelo A, Bucks C, et al. IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction. J Allergy Clin Immunol 2013;132:933-941.
24. Fux M, Pecaric-Petkovic T, Odermatt A, Hausmann OV, Lorentz A, Bischoff SC, Virchow JC, Dahinden CA. IL-33 is a mediator rather than a trigger of the acute allergic response in humans. Allergy 2014;69:216-222.
25. Brewster CE, Howarth PH, Djukanovic R, Wilson J, Holgate ST, Roche WR. Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 1990;3:507-511.
26. Laitinen A, Altraja A, Kampe M, Linden M, Virtanen I, Laitinen LA. Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. Am J Respir Crit Care Med 1997;156:951-958.
27. Jeffery PK, Wardlaw AJ, Nelson FC, Collins JV, Kay AB. Bronchial biopsies in asthma: An ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis 1989;140:1745-1753.
28. Chetta A, Fores IA, Del Donno M, Bertorelli G, Pesci A, Olivieri D. Airways remodelling is a distinctive feature of asthma and is related to severity of disease. Chest 1997;111: 852-857.
29. Sont JK, Willems LNA, Bel HE, van Krieken JH, Vandenbroucke JP, Sterk PJ. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guideline to long-Term treatment. Am J Respir Crit Care Med 1999;159:1043-1051.
30. Kasahara K, Shiba K, Ozawa T, Okuda K, Adachi M. Correlation between the bronchial subepithelial layer and whole airway wall thickness in patients with asthma. Thorax 2002;57:242-246.
31. Payne DN, Rogers AV, Adelroth E, Bandi V, Guntupalli KK, Bush A, Jeffery PK. Early thickening of the reticular basement membrane in children with difficult asthma. Am J Respir Crit Care Med 2003; 167:78-82.
32. Saglani S, Lui S, Ullmann N, Campbell GA, Sherburn RT, Mathie SA, Denney L, et al. IL-33 promotes airway remodeling in pediatric patients with severe steroid-resistant asthma. J Allergy Clin Immunol 2013;132:676-685e13.